Literature DB >> 27124793

WALDENSTRÖM'S MACROGLOBULINEMIA MASQUERADING AS BIRDSHOT CHORIORETINOPATHY.

Jane S Kim1, Laurence Jaworski, Dipti Patel-Donnelly, Robert B Nussenblatt, H Nida Sen.   

Abstract

PURPOSE: To describe Waldenström's macroglobulinemia (WM) as a masquerade syndrome.
METHODS: Case report.
RESULTS: A 59-year-old human leukocyte antigen (HLA)-A29-negative white male presented with a 7-year history of floaters, progressive vision loss, and poor contrast sensitivity along with choroidal lesions suggestive of birdshot chorioretinopathy (BCR). Fluorescein angiography, fundus autofluorescence, and indocyanine green angiography showed multiple areas of hyperfluorescence and hypofluorescence. Electroretinography showed reduced cone and rod responses. Comprehensive workup for infectious, paraneoplastic, and other causes including sarcoidosis was negative at the time. The patient was treated with multiple immunomodulatory agents without any significant improvement. Two years after initial presentation, the patient developed normocytic anemia and high levels of inflammatory markers. Further workup yielded a diagnosis of WM. His choroidal lesions were significantly reduced after treatment with rituximab and bendamustine.
CONCLUSION: We report a case of WM masquerading as BCR. Other indolent diseases should be considered in the differential diagnosis for HLA-A29-negative patients presenting with birdshot-like lesions, especially if they are clinically unresponsive to multiple systemic immunosuppressive agents.

Entities:  

Mesh:

Year:  2017        PMID: 27124793      PMCID: PMC5083234          DOI: 10.1097/ICB.0000000000000316

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  10 in total

1.  Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial.

Authors:  Eric B Suhler; Lyndell L Lim; Robert M Beardsley; Tracy R Giles; Sirichai Pasadhika; Shelly T Lee; Alexandre de Saint Sardos; Nicholas J Butler; Justine R Smith; James T Rosenbaum
Journal:  JAMA Ophthalmol       Date:  2014-05       Impact factor: 7.389

2.  Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.

Authors:  Eric B Suhler; Lyndell L Lim; Robert M Beardsley; Tracy R Giles; Sirichai Pasadhika; Shelly T Lee; Alexandre de Saint Sardos; Nicholas J Butler; Justine R Smith; James T Rosenbaum
Journal:  Ophthalmology       Date:  2014-06-20       Impact factor: 12.079

Review 3.  Are you sure this is Waldenstrom macroglobulinemia?

Authors:  Irene M Ghobrial
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 4.  Birdshot chorioretinopathy.

Authors:  Kayur H Shah; Ralph D Levinson; Fei Yu; Raquel Goldhardt; Lynn K Gordon; Christine R Gonzales; John R Heckenlively; Peter J Kappel; Gary N Holland
Journal:  Surv Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 6.048

5.  Macular oedema following rituximab infusion in two patients with Wegener's granulomatosis.

Authors:  Guillaume Bussone; Godefroy Kaswin; Mathilde de Menthon; Emmanuelle Delair; Antoine P Brézin; Loïc Guillevin
Journal:  Clin Exp Rheumatol       Date:  2010 Jan-Feb       Impact factor: 4.473

6.  Waldenström's macroglobulinemia-associated retinopathy.

Authors:  H Nida Sen; Chi-Chao Chan; Rafael C Caruso; Robert N Fariss; Robert B Nussenblatt; Ronald R Buggage
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

7.  Ocular manifestations of multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy.

Authors:  J Orellana; A H Friedman
Journal:  Surv Ophthalmol       Date:  1981 Nov-Dec       Impact factor: 6.048

Review 8.  HLA typing in uveitis: use and misuse.

Authors:  Katherine J Zamecki; Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-02       Impact factor: 5.258

9.  Choroidal lymphoma: clinical features and association with systemic lymphoma.

Authors:  Arman Mashayekhi; Shripaad Y Shukla; Jerry A Shields; Carol L Shields
Journal:  Ophthalmology       Date:  2013-08-23       Impact factor: 12.079

Review 10.  Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management.

Authors:  Morie A Gertz
Journal:  Am J Hematol       Date:  2013-06-20       Impact factor: 10.047

  10 in total
  1 in total

1.  Multimodal imaging in immunogammopathy maculopathy secondary to Waldenstrom's macroglobulinemia: a case report.

Authors:  Hui-Rong Xu; Jie Zhu; Xiao-Yan Xie; Jun Zhu; Fang Chen
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.